Zimmer Biomet Holdings (ZBH) EBT (2009 - 2026)

Zimmer Biomet Holdings' EBT history runs 18 years deep, the most recent figure standing at $301.3 million for Q1 2026.

• On a quarterly basis, EBT rose 31.57% year-over-year to $301.3 million in Q1 2026; TTM through Mar 2026 was -$55.2 million, a 120.78% decrease from a year earlier, with the FY2025 full-year figure at -$127.5 million, down 150.64% from the prior year.
• EBT improved to $301.3 million in Q1 2026 per ZBH's latest filing, from -$860.3 million in the prior quarter.
• Across five years, EBT topped out at $302.2 million in Q2 2024 and bottomed at -$860.3 million in Q4 2025.
• The 5-year median for EBT is $224.6 million (2025), against an average of $125.8 million.
• Across the five-year window, EBT soared 183.4% in 2023 and slumped 274.27% in 2024, its largest moves.
• Year by year, EBT stood at $167.6 million in 2022, then surged by 69.75% to $284.5 million in 2023, then slumped by 274.27% to -$495.8 million in 2024, then slumped by 73.52% to -$860.3 million in 2025, then jumped by 135.02% to $301.3 million in 2026.
• Per Business Quant, the three latest ZBH EBT figures stand at $301.3 million (Q1 2026), -$860.3 million (Q4 2025), and $279.2 million (Q3 2025).